Michelle A. Albert, MD, MPH

Michelle A. Albert, MD, MPH
MD, University of Rochester School of Medicine
MPH, Harvard School of Public Health

Phone: (415) 514-0092
Fax: (415) 502-7949
Email: Michelle.Albert@ucsf.edu
 

UCSF Profiles

Research interests:

I recently transitioned to my current role as a physician-scientist and Director of the Center for the Study of Adversity and Cardiovascular Disease in the Division of Cardiovascular Medicine at University of California, San Francisco, after serving as the Vivian Allen Beaumont Endowed Chair and Chief of Cardiovascular Medicine at Howard University. Prior to my stint at Howard, I served for over a decade as a cardiologist, cardiovascular epidemiologist, and Director of Behavioral and Neurocardiovascular Cardiology at the Brigham and Women’s Hospital in Boston, MA where my clinical responsibilities focused on caring for the most critically ill cardiovascular patients at my institution. My research seeks to forge links between preventive medicine, public policy and scientific research. Given that cardiovascular disease can be prevented by appropriate risk stratification and implementation of strategies to reduce morbidity and mortality in at risk populations, my research involves investigation of the interface between race/ethnicity, social determinants of health, biochemical markers of cardiovascular disease (CVD) risk and CVD outcome. I am involved in the design, conduct and analysis of multiple studies utilizing various national cohorts and randomized trials, including the Women’s Health Study (WHS), Physician’s Health Study, Black Women’s Health Study, Dallas Heart Study, the Multi-ethnic Study of Atherosclerosis, and the Jackson Heart Study. The overarching theme of my work in these cohorts involves the epidemiology of cardiovascular disease as it relates to hemostasis/thrombosis, inflammation, race/ethnicity, socioeconomic status and psychological stress, including discrimination and neighborhood stress. I have served as the scientific director of the Pravastatin Inflammation CRP Evaluation Trial (PRINCE), and the principal investigator of Robert Wood Johnson and Doris Duke grants aimed at examining novel risk factors of CVD risk in different race/ethnic groups and stress related to discrimination among black women. I am currently the PI of an NIH based RO1, entitled "Cumulative Stress and CVD Risk among middle aged and older women. Besides experience with working on projects that utilize large databases with biochemical information, I am also actively working on projects that employ the use of neuroimaging to better understand cardiovascular disease risk.

Professional honors and awards:

  • 1986 -1990 Charles Dana Scholar, Haverford College PA 1989 Gertrude Heller Award, Haverford College PA
  • 1992 Massachusetts General Hospital/Merck Fellowship Research Award, Boston MA
  • 1994 -1998 Medical Intern, Resident and Chief Resident, Columbia University Presbyterian Hospital, NY 1997 American Board of Internal Medicine, Diplomate in Internal Medicine
  • 1998 Instructor in Clinical Medicine, Department of Medicine, Columbia University NY
  • 1998 -2002 Clinical and Research Fellow in Cardiovascular Medicine, Brigham & Women’s Hospital, MA 1998 Finalist, Lanneac Society Young Clinician Award, American Heart Association, Atlanta GA 2001 Brigham and Women’s Hospital/Kraft Minority Faculty Development Award
  • 2001 Finalist, Jeremiah and Rose Stamler Research Award for New Investigators, American Heart Association, San Antonio TX
  • 2002 Instructor in Medicine, Harvard Medical School, Boston MA
  • 2003 Learner Young Investigator Award – Cardiovascular Medicine, Brigham and Women’s Hospital 2003 American Board of Internal Medicine, Diplomate in Cardiovascular Medicine
  • 2004 Herbert W. Nickens Epidemiology Award, Association of Black Cardiologists, Inc 2004 Assistant Professor in Medicine, Harvard Medical School, Boston MA
  • 2005 Elected Fellow, American College of Cardiology
  • 2006 J Ira and Nikki Harris Family Research Award, Cardiovascular Division Brigham and Women’s Hospital, MA
  • 2007 Winner, Best Science Award, Scientific Sessions Poster Competition, American Heart Association Annual Scientific Sessions, Orlando FL
  • 2008-2009 Harvard Business School, Selected Member of Brigham Leadership Program
  • 2009 Director of Behavioral and Neurocardiovascular Medicine, Cardiovascular Division, Brigham & Women’s Hospital
  • 2012 Associate Professor in Medicine, Harvard Medical School, Boston MA
  • 2012-2014 Vivian Allen Beaumont Endowed Professor & Chair, Chief of Cardiovascular Medicine, Howard University College of Medicine
  • 2012 Winner, Second Annual Heart of Women's credo Award, American College of Cardiology 2013- Adjunct Professor of Medicine, Johns Hopkins Medicine
  • 2014 Elected Fellow, American Heart Association
  • 2014 Elected Member, Association of Academic Minority Physicians 2015 The Haverford Alumni Award
  • 2015 Elected Fellow, Association of University Cardiologists (Elected 2015 Meeting, Induction 2016) 2016-2020 NIH/NIA: Biobehavioral and behavioral Processes Review Group: Mechanism of Emotion,
  • Stress & Health Standing Study Section (MESH)

Selected publications:

  1. Albert MA, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE Trial): a randomized trial and cohort study. JAMA 2001;286(1):64-70.
  2. Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 2004; 93(10):1238- 42.
  3. Albert MA, Pare G, Morris A, Rose L, Buring J, Ridker PM, Zee R. Candidate Genetic variants in Fibrinogen, methylenetetrahydrofolate reductase and Intercellular adhesion molecule-1 associated with Atherosclerosis and their baseline plasma levels among various Race/ethnic groups. American Heart Journal 2009; 157(4): 777-83.
  4. Albert, MA, Glynn RJ, Fonseca FAH, Lorenzatti AJ, Ferdinand KC, MacFayden JG, Ridker PM. Race, Ethnicity and the Efficacy of Rosuvastatin in Primary Prevention: The JUPITER Trial. American Heart Journal 2011; 162(1): 106-14.
  5. Albert MA, Glynn RJ, Buring J, Ridker PM. Impact of Traditional and Novel risk factors on the relationship between Socioeconomic Status and incident Cardiovascular events. Circulation 2006; 114(24):2619-26.
  6. Conen D, Glynn RJ, Ridker PM, Buring JE, Albert MA. Socioeconomic Status, Blood Pressure Progression and incident Hypertension in a prospective cohort of female health professionals. European Heart Journal 2009; 30 (11) 1378-84.
  7. Lee TC, Glynn RJ, Pena JM, Paynter NP, Conen D, Ridker PM, Pradhan AD, Buring JE, Albert MA. Socioeconomic Status and incident type 2 Diabetes Mellitus: Data from the Women's Health Study. PLoS ONE 2011; 6(12) e27670.
  8. Albert MA, Ayanian JZ, Silbaugh TS, Lovett A, Resnic F, Jacobs A, Normand, SL. Early results of Massachusetts Health Care Reform on Racial, Ethnic and Socioeconomic Disparities in Cardiovascular Care. Circulation 2014; 129 (24):2528-38.
  9. Slopen NS, Ying C, Priest N, Albert MA, Williams DR. Emotional and instrumental support during childhood and biological dysregulation in mid-life. Preventive Medicine 2016 (in press).
  10. Slopen NS, Williams DR, Roberts AL, Albert MA. Childhood Adversity, Adult Neighborhood Context and Cumulative Biological Risk in Adulthood”. Psychosomatic Medicine 2014 Sep;76 (7):481-9.
  11. Powell-Wiley TM, Ayers CR, De Lemos JA, Lakoski SG, Vega GL, Grundy S, Das SR, Banks-Richard K, Albert MA. Relationship between Perceptions about Neighborhood Environment and Prevalent Obesity: Data from the Dallas Heart Study. Obesity 2013; E14-21.
  12. Slopen N, Glynn RJ, Buring JE, Lewis TT, Williams DR, Albert MA. Job Strain, Job Insecurity and incident cardiovascular disease in the Women's Health Study: Results from a 10 year prospective study. PLoS ONE 2012; e40512